share_log

新銳醫藥:截至2024年9月30日之股份發行人的證券變動月報表

NEW RAY MEDIC: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024

HKEX ·  Oct 3, 2024 16:37

Summary by Moomoo AI

新銳醫藥國際控股有限公司(新銳醫藥)於2024年10月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年9月30日的股份變動情況。報告顯示,新銳醫藥的法定/註冊股本維持在3,000,000,000港元,每股面值0.05港元,總額達150,000,000港元,本月無變動。已發行股份(不包括庫存股份)數目為1,671,846,657股,本月亦無增減。此外,根據2013年10月25日採納的購股權計劃,公司上月底結存的股份期權數目為128,200,000股,本月內無變動。公司確認所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權,並遵守相關上市規則及法律規定。
新銳醫藥國際控股有限公司(新銳醫藥)於2024年10月3日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年9月30日的股份變動情況。報告顯示,新銳醫藥的法定/註冊股本維持在3,000,000,000港元,每股面值0.05港元,總額達150,000,000港元,本月無變動。已發行股份(不包括庫存股份)數目為1,671,846,657股,本月亦無增減。此外,根據2013年10月25日採納的購股權計劃,公司上月底結存的股份期權數目為128,200,000股,本月內無變動。公司確認所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權,並遵守相關上市規則及法律規定。
New ray medic international holdings limited (New ray medic) submitted the latest monthly securities change report to the Hong Kong Exchanges and Clearing Limited on October 3, 2024, reporting the shareholding changes as of September 30, 2024. The report shows that the statutory/registered share capital of New Ray Med reached HKD 3,000,000,000, with a face value of HKD 0.05 per share, totaling HKD 150,000,000, with no changes this month. The number of issued shares (excluding treasury shares) is 1,671,846,657 shares, with no increase or decrease this month. In addition, according to the share options plan adopted on October 25, 2013, the number of share options held by the company at the end of last month was 128,200,000 shares, with no changes this month. The company confirms that all securities issuance or transfer of treasury shares have been authorized by the board of directors and comply with relevant listing rules and legal requirements.
New ray medic international holdings limited (New ray medic) submitted the latest monthly securities change report to the Hong Kong Exchanges and Clearing Limited on October 3, 2024, reporting the shareholding changes as of September 30, 2024. The report shows that the statutory/registered share capital of New Ray Med reached HKD 3,000,000,000, with a face value of HKD 0.05 per share, totaling HKD 150,000,000, with no changes this month. The number of issued shares (excluding treasury shares) is 1,671,846,657 shares, with no increase or decrease this month. In addition, according to the share options plan adopted on October 25, 2013, the number of share options held by the company at the end of last month was 128,200,000 shares, with no changes this month. The company confirms that all securities issuance or transfer of treasury shares have been authorized by the board of directors and comply with relevant listing rules and legal requirements.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more